|

Apremilast Clinical Trials

3 actively recruiting trials across 1 location

Also known as: AMG 407, CC-10004, Otezla, Otezla®

Pipeline

Phase 1: 1Phase 3: 2

Top Sponsors

  • Amgen2
  • National Institute of Mental Health (NIMH)1

Indications

  • Arthritis2
  • Active Juvenile Psoriatic Arthritis1
  • Behçet's Disease1
  • Juvenile Psoriatic Arthritis1
  • Depression1

Other2 trials

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Phase 3
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Phase 3

Bethesda, Maryland1 trial

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

National Institutes of Health Clinical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.